52-week range
Price risk
Balance sheet & cash
Was the rally earned?
Partly.
- Most of the rise came from investors paying a higher multiple (P/E 14.2x to 28.1x); per-share earnings added 5 points.
- The share count barely moved.
Partly.
- Most of the rise came from investors paying a higher multiple (P/E 17.2x to 28.1x); per-share earnings added 20 points.
- The share count barely moved.
Both mattered.
- Per-share earnings added 655 points and the multiple added 875 points (P/E 5.7x to 28.1x).
- The share count barely moved.
What do "pts" mean?
"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.
Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.
Net profit is trailing twelve months as reported with a 60-day lag.
Is it expensive against its own past and its peers?
The chart loads when you open this tab.
The chart loads when you open this tab.
How to read this
Shaded band: 10th to 90th percentile of the company's own P/E history; dashed line: its median; orange line: sector median (companies with a positive multiple, at least 5 in the sector).
Sector figures are built from today's listed companies, so they exclude companies that are no longer listed.
What is the price implying?
At a P/E of 29.9x, the price would imply about 18.4%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.
Below the ₹1,000 cr market-cap floor used for the lists.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Commercial Services The market-wide Expectations lists
What changed?
- Oct '26Volume reached 6.1x its 50-day median on 2026-10-01; price +2.8% that day.
- Sep '26Year-on-year EPS growth turned positive.
- Sep '26Regained the 2024-01 peak, 18 months after the low.
- Sep '26P/E crossed above the 90th percentile of its own history to date (25.9x).
- Sep '26Volume reached 13.1x its 50-day median on 2026-09-04; price +3.6% that day.
- May '26Volume reached 5.9x its 50-day median on 2026-05-06; price +11.2% that day.
- Mar '26Revenue (TTM) reached a new high of ₹86 cr.
- Feb '26Volume reached 11.9x its 50-day median on 2026-02-10; price +5.0% that day.
Show 22 earlier events
- Oct '25Volume reached 24.1x its 50-day median on 2025-10-17; price +5.3% that day.
- Jun '25Year-on-year EPS growth turned negative.
- Jun '25Slipped to the 3rd quartile of Commercial Services on EPS growth (from the 2nd quartile).
- May '25Volume reached 5.3x its 50-day median on 2025-05-19; price -9.3% that day.
- Mar '25Fell 70% from the Jan 2024 peak to the Mar 2025 low.
- Mar '25Slipped to the 2nd quartile of Commercial Services on EPS growth (from the top quartile).
- Mar '25Volume reached 6.2x its 50-day median on 2025-03-20; price +10.7% that day.
- Dec '24Revenue (TTM) reached a new high of ₹76 cr.
- Oct '24Volume reached 15.4x its 50-day median on 2024-10-16; price +14.6% that day.
- Aug '24Volume reached 12.4x its 50-day median on 2024-08-27; price +8.1% that day.
- Jun '24Revenue (TTM) reached a new high of ₹75 cr.
- Apr '24Volume reached 10.5x its 50-day median on 2024-04-16; price +4.8% that day.
- Jan '24Volume reached 9.8x its 50-day median on 2024-01-23; price -12.1% that day.
- Nov '23Regained the 2022-10 peak, 8 months after the low.
- Nov '23P/E crossed above the 90th percentile of its own history to date (27.9x).
- Nov '23Volume reached 20.3x its 50-day median on 2023-11-08; price +14.8% that day.
- Sep '23Volume reached 5.4x its 50-day median on 2023-09-05; price +5.0% that day.
- Jun '23Revenue (TTM) reached a new high of ₹62 cr.
- Jun '23Moved into the top quartile of Commercial Services on EPS growth (from the 2nd quartile).
- May '23Volume reached 16.9x its 50-day median on 2023-05-02; price +17.8% that day.
- Mar '23Fell 53% from the Oct 2022 peak to the Mar 2023 low.
- Oct '22Regained the 2022-09 peak, 1 month after the low.
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Are profits backed by cash?
5 of 7 checks are within range, 2 near a threshold.
Tap a check to see how it is measured.
Other income reliance10%Within range
Other income as a share of pre-tax profit (trailing twelve months): 10.1%. Bands: below 15%, 15% to 35%, above 35%.
Tax rate25%Within range
Median quarterly effective tax rate over about 2.5 years: 25.3%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.
Cash conversion0.73xNear threshold
Operating cash flow divided by net profit over the last three fiscal years: 0.73x (cash from operations ₹64 cr, net profit ₹88 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.
Free cash flow5 of 5 yrsWithin range
Fiscal years with positive free cash flow in the last 5: 5. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history+33 daysNear threshold
Debtor days are above the median of the previous three fiscal years by 33 days (164 vs 131). Bands: under 15 days, 15 to 45, over 45.
Capital work in progress0% of fixed assetsWithin range
Capital work-in-progress is 0% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days-46 days / 2 yrsWithin range
Days payable changed by -46 over two years. Bands: rise of up to 30 days; more than 30 days.
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
Who has been buying and selling?
- Over 2 years, promoters added 1.8 pts.
- The number of shareholders fell from 19,179 to 16,909 (-12%) between Dec 2023 and Jun 2026.
Holdings, Jun '26
How each group changed
Number of shareholders
Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.
How rough has the ride been?
Monthly share price
Last 90 trading days
Drawdown from peak
Largest drawdowns
-69.8% (2024-01 peak to 2025-03 low, recovered 2026-09)
-53.2% (2022-10 peak to 2023-03 low, recovered 2023-11)
-50.9% (2020-12 peak to 2021-03 low, recovered 2022-01)
Most recent volume spikes
2026-10-01: 6.1x the 50-day median, price +2.8% that day
2026-09-24: 12x the 50-day median, price +4.9% that day
2026-09-21: 9.1x the 50-day median, price +0.3% that day
Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).
Where does it rank among Commercial Services peers?
Each cell is the company's percentile rank among its Commercial Services peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Commercial Services sector page Watch it move against Commercial Services in the Observatory
What else looks like this?
Companies with the most similar financial profile today, regardless of industry.
| Company | Sector | Similarity | Closest on |
|---|---|---|---|
| EMKAY TOOLS (ETL) | Producer Manufacturing | 59% | debt/equity, revenue |
| GANDHI SPECIAL TUBES (GANDHITUBE) | Non-Energy Minerals | 59% | debt/equity, ROCE |
| JAGSONPAL PHARMACEUTICALS LIMI (JAGSNPHARM) | Health Technology | 57% | revenue, P/E |
| SHRI AHIMSA NATURALS (SHRIAHIMSA) | Consumer Non-Durables | 55% | revenue, P/E |
| WEALTH FIRST PORTFOLIO MGR (WEALTH) | Finance | 55% | debt/equity, revenue |
| VINSYS IT SERVICES (VINSYS) | Commercial Services | 37% | volatility, P/E |
| ICRA (ICRA) | Commercial Services | 35% | operating margin, revenue growth |
| CARE RATINGS (CARERATING) | Commercial Services | 31% | P/E, ROCE |
Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.
What happened next to similar setups
- We found 50 past situations where a non-financial company looked like GLOBAL EDUCATION LTD today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
- Over the following 12 months the middle half of them returned −26% to +35% vs the market, against −1% for all non-financial companies in the same months.
- The gap against the base rate (+1.5%, 80% range −16.6% to +14.8%) is within what chance and overlapping periods produce.
Where the 50 outcomes landed
Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 4 beyond the range shown, drawn at the edge
50 past situations · 50 companies · 30 months · 2020–2025
The closest matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| MPSLTD Consumer Services |
Jan 2025 | 38x | 36% | +83% | 0% | −33% |
| JBCHEPHARM Health Technology |
Jul 2020 | 21x | 23% | +96% | 0% | +58% |
| FDC Health Technology |
Jul 2020 | 21x | 21% | +93% | 0% | −21% |
| NUCLEUS Technology Services |
Sep 2020 | 22x | 21% | +111% | −3% | −47% |
| VOLTAMP Producer Manufacturing |
Jul 2022 | 27x | 19% | +125% | 0% | +16% |
Show the other 3 matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| CARERATING Commercial Services |
May 2025 | 45x | 21% | +78% | 0% | −12% |
| SUPRIYA Health Technology |
Oct 2024 | 37x | 22% | +149% | −4% | +21% |
| NAVINFLUOR Process Industries |
Jun 2020 | 20x | 21% | +129% | −1% | +42% |
How reliable is this?
Matched on P/E, P/S, ROCE, operating margin, debt/equity, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: P/E, P/S and revenue growth. Not used (unavailable for this company): interest cover. One match per company and at most 7 from any one month.
Independent periods: the matches fall in 5 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.
Monthly history (71 months)
| Month | P/E | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|---|
| 2026-10 | 28.1x | ₹93 cr | 19.9% | 29.0% | 0.0x |
| 2026-09 | 25.9x | ₹93 cr | 19.9% | 29.0% | 0.0x |
| 2026-08 | 20.5x | ₹94 cr | 20.2% | 29.0% | 0.0x |
| 2026-07 | 20.0x | ₹94 cr | 20.2% | 29.0% | 0.0x |
| 2026-06 | 20.0x | ₹94 cr | 20.2% | 29.0% | 0.0x |
| 2026-05 | 22.8x | ₹86 cr | 20.5% | 37.0% | 0.0x |
| 2026-04 | 23.4x | ₹86 cr | 20.5% | 37.0% | 0.0x |
| 2026-03 | 21.0x | ₹86 cr | 20.5% | 37.0% | 0.0x |
| 2026-02 | 23.3x | ₹74 cr | 19.9% | 37.0% | 0.0x |
| 2026-01 | 19.0x | ₹74 cr | 19.9% | 37.0% | 0.0x |
| 2025-12 | 20.8x | ₹74 cr | 19.9% | 37.0% | 0.0x |
| 2025-11 | 16.9x | ₹73 cr | 22.9% | 37.0% | 0.0x |
| 2025-10 | 14.2x | ₹73 cr | 22.9% | 37.0% | 0.0x |
| 2025-09 | 13.1x | ₹73 cr | 22.9% | 37.0% | 0.0x |
| 2025-08 | 12.1x | ₹72 cr | 25.5% | 37.0% | 0.0x |
| 2025-07 | 12.1x | ₹72 cr | 25.5% | 37.0% | 0.0x |
| 2025-06 | 11.4x | ₹72 cr | 25.5% | 37.0% | 0.0x |
| 2025-05 | 10.6x | ₹74 cr | 32.6% | 58.0% | 0.0x |
| 2025-04 | 10.0x | ₹74 cr | 32.6% | 58.0% | 0.0x |
| 2025-03 | 7.3x | ₹74 cr | 32.6% | 58.0% | 0.0x |
| 2025-02 | 8.1x | ₹76 cr | 36.1% | 58.0% | 0.0x |
| 2025-01 | 9.7x | ₹76 cr | 36.1% | 58.0% | 0.0x |
| 2024-12 | 11.3x | ₹76 cr | 36.1% | 58.0% | 0.0x |
| 2024-11 | 11.8x | ₹75 cr | 36.4% | 58.0% | 0.0x |
| 2024-10 | 11.4x | ₹75 cr | 36.4% | 58.0% | 0.0x |
| 2024-09 | 11.7x | ₹75 cr | 36.4% | 58.0% | 0.0x |
| 2024-08 | 12.4x | ₹75 cr | 38.1% | 58.0% | 0.0x |
| 2024-07 | 11.7x | ₹75 cr | 38.1% | 58.0% | 0.0x |
| 2024-06 | 10.2x | ₹75 cr | 38.1% | 58.0% | 0.0x |
| 2024-05 | 17.3x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2024-04 | 22.2x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2024-03 | 20.7x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2024-02 | 23.6x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2024-01 | 27.9x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2023-12 | 27.0x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2023-11 | 27.9x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2023-10 | 17.2x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2023-09 | 17.0x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2023-08 | 17.0x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2023-07 | 15.8x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2023-06 | 17.5x | ₹62 cr | 35.4% | 54.0% | 0.0x |
| 2023-05 | — | ₹39 cr | 23.4% | — | 0.0x |
| 2023-04 | — | ₹39 cr | 23.4% | — | 0.0x |
| 2023-03 | — | ₹39 cr | 23.4% | — | 0.0x |
| 2023-02 | — | ₹39 cr | 23.4% | — | 0.0x |
| 2023-01 | — | ₹39 cr | 23.4% | — | 0.0x |
| 2022-12 | — | ₹39 cr | 23.4% | — | 0.0x |
| 2022-11 | — | ₹39 cr | 23.4% | — | 0.0x |
| 2022-10 | — | ₹39 cr | 23.4% | — | 0.0x |
| 2022-09 | — | ₹39 cr | 23.4% | — | 0.0x |
| 2022-08 | 40.8x | ₹39 cr | 23.4% | — | 0.0x |
| 2022-07 | 34.4x | ₹39 cr | 23.4% | — | 0.0x |
| 2022-06 | 28.6x | ₹39 cr | 23.4% | — | 0.0x |
| 2022-05 | 12.2x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2022-04 | 10.6x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2022-03 | 9.0x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2022-02 | 9.0x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2022-01 | 11.4x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-12 | 8.3x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-11 | 5.1x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-10 | 5.7x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-09 | 5.7x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-08 | 5.7x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-07 | 6.0x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-06 | 6.5x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-05 | 6.8x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-04 | 5.9x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-03 | 4.7x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-02 | 6.3x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2021-01 | 6.9x | ₹26 cr | 21.6% | 33.0% | 0.0x |
| 2020-12 | 8.7x | ₹26 cr | 21.6% | 33.0% | 0.0x |